View larger
BID antibody
FT-FNab00892
New product
100 µg
Ao comprar este produto pode ganhar até 1 ponto de fidelização. Seu carrinho totalizará 1 ponto de fidelização que podem ser convertidos num vale de desconto de 4.00EUR.
Data sheet
| Size | 100µg |
| Storage Conditions | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
| Applications | ELISA, WB, IHC |
| Target | BID |
| Research Area | Cancer, Signal Transduction, Metabolism, Cell Division and Proliferation |
| Form | liquid |
| Recomended Dilution | WB: 1:500-1:2000 |
| Type Clonality | polyclonal |
| Immunogen | BH3 interacting domain death agonist |
| Minimum Purity | ≥95% as determined by SDS-PAGE |
| Synonyms | BH3-interacting domain death agonist|p22 BID (BID)|BH3-interacting domain death agonist p15 Alternative names: p15 BID|BH3-interacting domain death agonist p13 Alternative names: p13 BID|BH3-interacting domain death agonist p11 Alternative names: p11 BID| |
| Host | Rabbit |
| UniProt ID | P55957 |
| Gene ID | 637 |
| Purification | Immunogen affinity purified |
| Iso type | IgG |
| Reactivity | Human, Mouse |
| Observed MW | 22 kDa |
| Background | The major proteolytic product p15 BID allows the release of cytochrome c(By similarity). Isoform 1, isoform 2 and isoform 4 induce ICE-like proteases and apoptosis. Isoform 3 does not induce apoptosis. Counters the protective effect of Bcl-2. |
More info
BID antibody